Yüklüyor......

Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: A Phase I/IIa trial of atorvastatin

INTRODUCTION: Since the 1980s, the primary treatment of acute Kawasaki disease (KD) has been intravenous immunoglobulin and aspirin. However, 5-10% of children with acute KD will develop coronary artery abnormalities despite treatment within the first ten days after fever onset. There is no approved...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Expert Opin Orphan Drugs
Asıl Yazarlar: Tremoulet, Adriana H, Jain, Sonia, Burns, Jane C
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4979608/
https://ncbi.nlm.nih.gov/pubmed/27525197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2015.1066246
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!